Our Solutions   by Brands   Romstim   Perzea Injection

Perzea Injection

Pertuzumab 420mg vial for HER2+ breast cancer therapy

*To be consumed as directed by physician.

Therapies:

Breast Cancer

Composition:

Pertuzumab 420 mg/14 ml

About Perzea Pertuzumab 420mg Injection for HER2+ Breast Cancer

Perzea Injection 420 mg/14 ml contains Pertuzumab 420 mg, a targeted anticancer medicine used in combination with other chemotherapy medicines for the treatment of HER2-positive breast cancer. It works by targeting HER2 receptors on cancer cells, helping slow or stop cancer growth.

Pertuzumab 420mg vial for HER2+ breast cancer therapy

*To be consumed as directed by physician.


Usage Instructions

  • Use Perzea Injection exactly as prescribed by your oncologist.
  • Do not stop treatment without consulting your doctor.
  • Regular monitoring may be required during therapy.

    • Benefits and Use

  • Perzea Injection is used in the treatment of HER2-positive breast cancer.
  • It works by binding to HER2 receptors on cancer cells, helping prevent their growth and spread.
  • When combined with other anticancer medicines, it improves treatment effectiveness and disease control.

    • Safety Information

  • Alcohol: It is not known whether alcohol interacts with Perzea Injection. Consult your doctor before consuming alcohol during treatment.
  • Pregnancy: Avoid use during pregnancy unless specifically advised by your doctor. Effective contraception is recommended during treatment and for at least 6 months after the last dose.
  • Breastfeeding: Consult your doctor before breastfeeding, as it may not be safe during treatment.
  • Driving: Perzea Injection may cause dizziness or infusion-related reactions. Avoid driving or operating machinery if you feel unwell.
  • Kidney Disease: Use with caution in patients with kidney disease. Inform your doctor about any existing kidney conditions.
  • Liver Disease: Use cautiously in patients with liver impairment. Liver function may need regular monitoring during treatment.

    • Ingredients

    Pertuzumab 420 mg/14 ml

    How to Use

  • Perzea Injection is administered as an intravenous (IV) infusion by a healthcare professional, usually once every 3 weeks.
  • Do not self-administer.
  • The dose and treatment duration are determined by your doctor based on your condition and response to therapy.

    • Storage Information

    Store in a refrigerator at 2°C to 8°C.